Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Real Estate
  • Software
  • Concealed Carry
  • Information Technology
Washingtoner

InventHelp Inventor Develops New Cap Key Wrench (SDK-148)
Washingtoner/10277700

Trending...
  • Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon
  • Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
  • Spokane: SPD Seeks Assistance in Locating Vehicle Associated in Hit and Run
PITTSBURGH, Dec. 13, 2024 ~ An inventor from Ocean Shores, Wash., has created a new handheld tool that aims to simplify the process of opening or closing cleanout caps or valves. The CAP KEY WRENCH, as it is called, was designed with the intention of providing a universal solution for accessing these caps below any surface level or within the interior of pipe configurations.

The patent-pending invention offers a specialized tool for easy access to different sized plumbing cleanout caps. This serves as an improved alternative to using conventional handheld tools, ultimately saving time and effort while reducing struggle, strain and potential damage. Its ergonomic design makes it easy to use, making it an ideal tool for contractors, plumbers, utility workers, and sewer scope inspection personnel.

More on Washingtoner
  • Roots, Rhythm & Joy Invites Neighbors to Find Community Through Music
  • Tacoma: Homicide Investigation – 1100 Commerce Street
  • Former Goddard Enterprises Managing Director Anthony Ali Joins STS Capital Partners as Managing Director and Partner
  • Heritage at Manalapan Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Homes
  • Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event

The original design was submitted to the Seattle sales office of InventHelp and is currently available for licensing or sale to manufacturers or marketers. For more information on this invention, interested parties can write to Dept. 23-SDK-148 at InventHelp's address: 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801. They can also call (412) 288-1300 ext. 1368 or visit http://www.InventHelp.com to learn more about InventHelp's Invention Submission Services.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026
  • Detroit Lawyer Steals $600,000 Settlement Meant to Protect Child
  • The TOPS Trap: Local AI Models Hallucinated Facts, Cited Real Sources, and Sounded Confident
  • Final Week to Register for Free Spokane Community Conference
  • Heritage at South Brunswick Announces Special Townhome Mortgage Rate Buydown
  • Heritage at Hopewell Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Townhomes
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton
  • Breathwork Certification in Seattle, Washington State: First Pacific Northwest Date Set
  • Author Robert A. Robinson Introduces Anarchy at the AYP:
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
  • AI Agents Are Getting Their Own Computers. HRTech Leading in Vertical Harness Development
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Spokane City Council Passes Community Safety Sales Tax
  • AutoProIT Achieves Cyber Essentials Certification, Reinforcing Its Commitment to Secure Digital Transformation
  • DayPass llega a ChatGPT y Claude
  • DayPass launches in ChatGPT and Claude
  • Renkeer Water Quality Sensors Support Efficient Operation of AI Liquid Cooling Systems
  • Victor Archibong Expands ItsArchiDuh Creator Brand
  • ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: Police Arrest Registered Sex Offender for Child Sexual Abuse Material - 322
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains - 206
  • CinderLabs Launches AI Agent Marketplace: Nine Pre-Built Agents for Regulated Industries - 161
  • Spokane: Convicted Felon Arrested in Vancouver After Eluding SPD Officers - 149
  • City of Spokane to Install First 'Emergency Streets' Lane Closure After Weekend Fatal Crash - 148
  • City of Tacoma Invites Community Members to Share Their Experience Crossing I-5 - 137
  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 120
  • Inglewood Associates and Gordon Brothers Provide Update on Sale Process for 925 Euclid Avenue in Cleveland - 105
  • JEGS Launches Transformed Digital Commerce Platform Powered by PhaseZero - 101
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process

Similar on Washingtoner

  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms
  • National Literacy and Workforce Readiness Crisis Sparks New Program Launching in Birmingham
  • New England Consulting Partners Celebrates 25 Years of Turnaround Management Solutions
  • RAS AP Consulting Releases Educational Resource to Help Organizations Prepare for IRS FIRE-to-IRIS Transition
  • Former Goddard Enterprises Managing Director Anthony Ali Joins STS Capital Partners as Managing Director and Partner
  • Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
  • Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee
  • Tax Tops the List as Wealthy Brits Plan Their Exit, La Vida Survey Finds
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute